Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Biolase Inc (BIOL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7489
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diode systems. Its laser systems find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontists, oral surgeons and other dental specialists. It also offers consumables products, other imaging system products and maintenance service. The company distributes its products through direct sales force, agents and distributors. It has operations in the Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.

Biolase Inc (BIOL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biolase Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
BIOLASE Technology Acquires 180 Waterlase MD Turbo Laser Systems From Henry Schein 12
Partnerships 13
Biolase Enters Into Licensing Agreement With Valem 13
Biolase Enters into Research Agreement with McGuire Institute 14
Biolase Enters into Agreement with IPG Photonics 15
Biolase Enters Into Distribution Agreement With Stratasys 16
Biolase To Enter Into Co-Development Agreement With Auris Surgical Robotics 17
Biolase Enters Into Co-Marketing Agreement With Sun Dental Labs For TRIOS 18
Biolase Enters Into Distribution Agreement With 3Shape For TRIOS 19
BIOLASE Enters Into Co-Marketing Agreement With Cefla Dental 20
Equity Offering 21
Biolase Plans to Raise Funds through Public Offering of Shares 21
Biolase Raises USD12 Million in Rights offering of Shares 22
Biolase Plans to Raise up to USD10 Million in Public Offering of Shares 23
Biolase Raises USD10 Million in Private Placement of Series D Preferred Stock 24
Biolase Raises USD10 Million in Private Placement of Preferred Stock 26
Biolase Raises USD35 Million in Private Placement of Shares 28
Biolase Raises USD12 Million in Private Placement of Shares 29
Biolase Completes Private Placement Of Common Stock For US$5 Million 30
Biolase Technology Files Registration Statement For Public Offering Of Securities For Up To US$12.5 Million 31
Biolase Completes Private Placement Of Shares For US$5 Million 32
Biolase Decreases Size Of Public Offering Of Securities For US$5 Million 33
Asset Transactions 34
Biolase Sells 159 Waterlase MD Turbo Laser Systems 34
Biolase Inc – Key Competitors 35
Biolase Inc – Key Employees 36
Biolase Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
May 02, 2018: BIOLASE Announces 2018 First Quarter Results 38
Nov 01, 2017: BIOLASE Reports 2017 Third Quarter and Nine-Month Results 40
Aug 07, 2017: BIOLASE Reports 2017 Second Quarter and Six-Month Results 42
May 03, 2017: BIOLASE Reports 2017 First Quarter Results 44
Mar 08, 2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results 46
Corporate Communications 48
Aug 08, 2018: BIOLASE names Todd A. Norbe President, Chief Executive Officer 48
Jun 19, 2018: BIOLASE Names Todd A. Norbe And Jess Roper As Board Directors 49
Apr 11, 2018: BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options 50
Apr 04, 2018: BIOLASE Names Garrett Sato To Board Of Directors 51
Mar 07, 2018: BIOLASE Secures $6 Million Revolving Line Of Credit 52
Oct 31, 2017: BIOLASE Appoints Richard B. Lanman to Board of Directors 53
Oct 02, 2017: BIOLASE Names John Beaver Senior Vice President, Chief Financial Officer 54
Sep 05, 2017: BIOLASE Names Jonathan T. Lord Chairman of the Board 55
May 05, 2017: BIOLASE Announces Management Change 56
Mar 13, 2017: BIOLASE Names James D. Surek Vice President Sales, Americas 57
Mar 01, 2017: BIOLASE Names Mark J. Nelson Chief Financial Officer 58
Jan 09, 2017: BIOLASE Announces Management Change 59
Legal and Regulatory 60
Jan 25, 2018: BIOLASE Rejects Frivolous, Abusive Patent Litigation 60
Jan 24, 2018: CAO Group Protects Its Diode Laser Patent Rights From Infringement By Biolase 61
Government and Public Interest 62
Mar 28, 2018: BIOLASE Announces Growing Awareness of Dental Lasers Among Pediatric Dentists, Demonstrating Shift Toward Pain-Free Dentistry 62
Other Significant Developments 63
Sep 12, 2018: BIOLASE Expands Its Initiative to Increase Dental Laser Awareness to Dallas-Fort Worth Area 63
May 09, 2018: BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California 64
Feb 15, 2018: BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education in Southern California 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66

List of Tables
Biolase Inc, Medical Equipment, Key Facts, 2017 2
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Deals By Market, 2012 to YTD 2018 9
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
BIOLASE Technology Acquires 180 Waterlase MD Turbo Laser Systems From Henry Schein 12
Biolase Enters Into Licensing Agreement With Valem 13
Biolase Enters into Research Agreement with McGuire Institute 14
Biolase Enters into Agreement with IPG Photonics 15
Biolase Enters Into Distribution Agreement With Stratasys 16
Biolase To Enter Into Co-Development Agreement With Auris Surgical Robotics 17
Biolase Enters Into Co-Marketing Agreement With Sun Dental Labs For TRIOS 18
Biolase Enters Into Distribution Agreement With 3Shape For TRIOS 19
BIOLASE Enters Into Co-Marketing Agreement With Cefla Dental 20
Biolase Plans to Raise Funds through Public Offering of Shares 21
Biolase Raises USD12 Million in Rights offering of Shares 22
Biolase Plans to Raise up to USD10 Million in Public Offering of Shares 23
Biolase Raises USD10 Million in Private Placement of Series D Preferred Stock 24
Biolase Raises USD10 Million in Private Placement of Preferred Stock 26
Biolase Raises USD35 Million in Private Placement of Shares 28
Biolase Raises USD12 Million in Private Placement of Shares 29
Biolase Completes Private Placement Of Common Stock For US$5 Million 30
Biolase Technology Files Registration Statement For Public Offering Of Securities For Up To US$12.5 Million 31
Biolase Completes Private Placement Of Shares For US$5 Million 32
Biolase Decreases Size Of Public Offering Of Securities For US$5 Million 33
Biolase Sells 159 Waterlase MD Turbo Laser Systems 34
Biolase Inc, Key Competitors 35
Biolase Inc, Key Employees 36
Biolase Inc, Subsidiaries 37

List of Figures
Biolase Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LipimetiX Development Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary LipimetiX Development Inc (LipimetiX), formerly LipimetiX LLC is a biopharmaceutical company that develops drugs to treat refractory hypercholesterolemia and hypertriglyceridemia, acute pancreatitis, coronary artery, and peripheral artery diseases. The company develops drugs based on chimeri …
  • Aptiv PLC:企業の戦略・SWOT・財務情報
    Aptiv PLC - Strategy, SWOT and Corporate Finance Report Summary Aptiv PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ZincX Resources Corp.:企業の戦略・SWOT・財務情報
    ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Publicis Groupe SA:企業の戦略・SWOT・財務情報
    Publicis Groupe SA - Strategy, SWOT and Corporate Finance Report Summary Publicis Groupe SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, perinatology, urology and electrosurgery, respiratory and OEM products. Its blood pressure monitor …
  • Town Health International Medical Group Ltd (3886):企業の財務・戦略的SWOT分析
    Summary Town Health International Medical Group Ltd (THIMGL), formerly Town Health International Investments Ltd, a subsidiary of Hong Kong Health Check and Medical Diagnostic Group Ltd, is a healthcare service provider. The organization offers medical platform, chain clinics, specialty centres, man …
  • Cafes Novell SA:企業の戦略・SWOT・財務分析
    Cafes Novell SA - Strategy, SWOT and Corporate Finance Report Summary Cafes Novell SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • DLF Limited:企業の戦略・SWOT・財務情報
    DLF Limited - Strategy, SWOT and Corporate Finance Report Summary DLF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Harvard Medical School-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Medical School (HMS), a subsidiary of Harvard University is a medical institute that offers education, research and clinical care services. The institute offers various degree programs such as bachelor's program, master's program, PhD program, and continuing education. It offers prog …
  • Cancer Genetics Inc (CGIX)-医療機器分野:企業M&A・提携分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic inform …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Merck & Co Inc (MRK):製薬・医療:M&Aディール及び事業提携情報
    Summary Merck & Co Inc (Merck) is a biopharmaceutical company that focuses on the discovery, development, manufacture and commercialization of prescription medicines, biologic therapies, vaccines and animal health products. It offers prescription products for treating cardiovascular, cancer, immune …
  • Zest Dental Solutions:医療機器:M&Aディール及び事業提携情報
    Summary Zest Dental Solutions (Zest Dental), formerly ZEST Anchors LLC is a medical device manufacturing company that manufactures, develops, and distributes dental solutions for the treatment of edentulous patients. The company’s products include dental removal tool, attachment processing materials …
  • Manhattan Associates Inc (MANH):企業の財務・戦略的SWOT分析
    Manhattan Associates Inc (MANH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Akorn Inc (AKRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including or …
  • Hanger, Inc.-医療機器分野:企業M&A・提携分析
    Summary Hanger, Inc. (Hanger) formerly Hanger Orthopedic Group, Inc., is a health care and medical device company. The company along with its subsidiaries offers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions. Hanger is one of the largest owner …
  • American Tower Corp (AMT):企業の財務・戦略的SWOT分析
    American Tower Corp (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Del Frisco’s Restaurant Group, Inc.:企業の戦略・SWOT・財務情報
    Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • TauRx Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆